JP2022510346A5 - - Google Patents

Info

Publication number
JP2022510346A5
JP2022510346A5 JP2021531369A JP2021531369A JP2022510346A5 JP 2022510346 A5 JP2022510346 A5 JP 2022510346A5 JP 2021531369 A JP2021531369 A JP 2021531369A JP 2021531369 A JP2021531369 A JP 2021531369A JP 2022510346 A5 JP2022510346 A5 JP 2022510346A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
group
carbon atoms
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021531369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022510346A (ja
Filing date
Publication date
Priority claimed from GB1819399.5A external-priority patent/GB2579253A/en
Application filed filed Critical
Publication of JP2022510346A publication Critical patent/JP2022510346A/ja
Publication of JP2022510346A5 publication Critical patent/JP2022510346A5/ja
Pending legal-status Critical Current

Links

JP2021531369A 2018-11-28 2019-11-27 抗菌アンチセンス剤 Pending JP2022510346A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1819399.5A GB2579253A (en) 2018-11-28 2018-11-28 Antibacterial antisense agents
GB1819399.5 2018-11-28
PCT/GB2019/053354 WO2020109792A1 (en) 2018-11-28 2019-11-27 Antibacterial antisense agents

Publications (2)

Publication Number Publication Date
JP2022510346A JP2022510346A (ja) 2022-01-26
JP2022510346A5 true JP2022510346A5 (cg-RX-API-DMAC7.html) 2022-11-09

Family

ID=65024582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021531369A Pending JP2022510346A (ja) 2018-11-28 2019-11-27 抗菌アンチセンス剤

Country Status (9)

Country Link
US (1) US20220106595A1 (cg-RX-API-DMAC7.html)
EP (1) EP3887520A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022510346A (cg-RX-API-DMAC7.html)
KR (1) KR20210098493A (cg-RX-API-DMAC7.html)
CN (1) CN113366107A (cg-RX-API-DMAC7.html)
AU (1) AU2019386368A1 (cg-RX-API-DMAC7.html)
CA (1) CA3121064A1 (cg-RX-API-DMAC7.html)
GB (1) GB2579253A (cg-RX-API-DMAC7.html)
WO (1) WO2020109792A1 (cg-RX-API-DMAC7.html)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130516A (en) * 1978-03-31 1979-10-09 Yuuichi Yamamura Acyllnnacetylmuramylpeptide derivativeeantigen combination
US5185444A (en) 1985-03-15 1993-02-09 Anti-Gene Deveopment Group Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
US5217866A (en) 1985-03-15 1993-06-08 Anti-Gene Development Group Polynucleotide assay reagent and method
EP0541486A1 (de) 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO2006104530A1 (en) * 2005-03-28 2006-10-05 Cell Works Therapeutics, Inc. Therapeutics targeted to renal cells
WO2014002039A1 (en) 2012-06-27 2014-01-03 Shire Ag Amphetamine prodrugs
WO2014205451A2 (en) * 2013-06-21 2014-12-24 Isis Pharmaceuticals, Inc. Compositions and methods for modulation of target nucleic acids
WO2015006740A2 (en) * 2013-07-11 2015-01-15 Alnylam Pharmaceuticals, Inc. Oligonucleotide-ligand conjugates and process for their preparation
EP2845607A1 (en) 2013-09-09 2015-03-11 University of Vienna Antisense oligonucleotides with improved pharmacokinetic properties
US9790495B2 (en) 2014-05-16 2017-10-17 Oregon State University Antisense antibacterial compounds and methods
CA2948568A1 (en) 2014-05-19 2015-11-26 David Greenberg Antisense antibacterial compounds and methods
WO2016108930A2 (en) 2014-12-31 2016-07-07 Geller Bruce L Antisense antibacterial compounds and methods
WO2016172615A1 (en) 2015-04-24 2016-10-27 University Of Delaware Synthetic n-acetyl-muramic acid derivatives and uses thereof
JPWO2017010575A1 (ja) * 2015-07-16 2018-04-26 協和発酵キリン株式会社 β2GPI遺伝子発現抑制核酸複合体
AU2016379399B2 (en) 2015-12-23 2022-12-08 Board Of Regents, The University Of Texas System Antisense antibacterial compounds and methods
US11142764B2 (en) 2015-12-23 2021-10-12 Board Of Regents, The University Of Texas System Antisense antibacterial compounds and methods
US11180756B2 (en) * 2017-03-09 2021-11-23 Ionis Pharmaceuticals Morpholino modified oligomeric compounds

Similar Documents

Publication Publication Date Title
JP7792371B2 (ja) GalNAc誘導体
JP7008056B2 (ja) 修飾されたサブユニット間結合および/または末端基を有するオリゴヌクレオチドアナログ
CN103619356B (zh) 肽寡核苷酸缀合物
CN100400045C (zh) 基于核酸的化合物及其使用方法
JP2023536320A5 (cg-RX-API-DMAC7.html)
JP2009523777A5 (cg-RX-API-DMAC7.html)
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2005533061A5 (cg-RX-API-DMAC7.html)
JP2004537517A5 (cg-RX-API-DMAC7.html)
JP2005533824A5 (cg-RX-API-DMAC7.html)
JP2006518197A5 (cg-RX-API-DMAC7.html)
WO2004074270A3 (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
JP2024511954A5 (cg-RX-API-DMAC7.html)
JP2022544538A5 (cg-RX-API-DMAC7.html)
JP2022040131A5 (cg-RX-API-DMAC7.html)
JP2011517697A5 (cg-RX-API-DMAC7.html)
JP2020534374A5 (cg-RX-API-DMAC7.html)
JP2009520695A5 (cg-RX-API-DMAC7.html)
JP2010518016A5 (cg-RX-API-DMAC7.html)
US20230383296A1 (en) Modified gapmer oligomers and methods of use thereof
JP2025515098A5 (cg-RX-API-DMAC7.html)
JP2008519848A5 (cg-RX-API-DMAC7.html)
NZ791481B2 (en) Immunomodulating urea azalides
CN118019530A (zh) 治疗病毒感染的方法
NZ791481A (en) Immunomodulating urea azalides